ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-OR41

Harnessing Expressed Single-Nucleotide Variation and Single-Cell RNA Sequencing to Define Immune Cell Chimerism in the Rejecting Kidney Transplant

Session Information

Category: Transplantation

  • 1901 Transplantation: Basic


  • Malone, Andrew F., Washington University in Saint Louis, Saint Louis, Missouri, United States
  • Wu, Haojia, Washington University in Saint Louis, Saint Louis, Missouri, United States
  • Gaut, Joseph, Washington University in Saint Louis, Saint Louis, Missouri, United States
  • Humphreys, Benjamin D., Washington University in Saint Louis, Saint Louis, Missouri, United States

In solid organ transplantation, donor derived immune cells are assumed to decline with time after surgery. Whether donor leukocytes persist within kidney transplants or play any role in rejection is unknown, however, in part because of limited techniques for distinguishing recipient and donor cells.


We performed paired whole exome sequencing of donor and recipient DNA and single cell RNA sequencing (scRNA-seq) of 5 human kidney transplant biopsy cores. Exome sequences were used to define single nucleotide variants (SNV) across all samples.


By analyzing expressed SNVs in the scRNA-seq dataset we could define recipient vs. donor cell origin for all 81,139 cells. The leukocyte donor to recipient ratio varied with rejection status for macrophages and with time post-transplant for lymphocytes. Recipient macrophages were characterized by inflammatory activation and donor macrophages by antigen presentation and complement signaling. Recipient origin T cells expressed cytotoxic and pro-inflammatory genes consistent with an effector cell phenotype whereas donor origin T cells are likely quiescent expressing oxidative phosphorylation genes relative to recipient T cells. Finally, both donor and recipient T cell clones were present within the rejecting kidney, suggesting lymphoid aggregation. Our results indicate that donor origin macrophages and T cells have distinct transcriptional profiles compared to their recipient counterparts and donor macrophages can persist for years post transplantation.


This study demonstrates the power of this approach to accurately define leukocyte chimerism in a complex tissue such as the kidney transplant coupled with the ability to examine transcriptional profiles at single cell resolution.

A-D) Donor origin Macrophage and Lymphocyte population variations with time and rejection status E) Macrophage pathway analysis by cell origin F) Dotplot of genes that define donor and recipient macrophages


  • NIDDK Support